SlideShare a Scribd company logo
Biostatistics
Lecture 10
Lecture 9 Review –
Measures of association
Measures of association
–
–
–
Risk difference
Risk ratio
Odds ratio
Calculation & interpretation
interval for each measure
of confidence
of association
2×2 table - Measures of association
Outcome - binary
Measure of Effect Formula
Risk difference p1-p0
Risk ratio p1 / p0
Odds ratio (d1/h1) / (d0/h0)
Differences in measures of association
• When there is no association between exposure and outcome,
–
–
–
risk difference = 0
risk ratio (RR) = 1
odds ratio (OR) = 1
•
•
Risk difference can be negative or positive
RR & OR are always positive
• For rare outcomes, OR ~ RR
• OR is always further from 1 than corresponding RR
– If RR > 1 then OR > RR
– If RR < 1 the OR < RR
Interpretation of measures of association
• RR & OR < 1, associated with a reduced risk / odds (may
protective)
be
– RR = 0.8 (reduced risk of 20%)
• RR
–
& OR > 1, associated with an increased risk / odds
RR = 1.2 (increased risk of 20%)
• RR & OR – further the risk is from 1, stronger the association
between exposure and outcome (e.g. RR=2 versus RR=3).
Comparing the outcome measure of two exposure groups
(groups 1 & 0)
s.e.(log RR) = − + −e
eR
(log
e
OR )
d h d h
Outcome
variable –
data type
Population
parameter
Estimate
of
population
parameter
from
sample
Standard error of
loge(parameter)
95% Confidence interval of
loge(population parameter)
Categorical
Population
risk ratio
p1/p0 1 1 1 1
d1 n1 d0 n0
logeRR
±1.96× s.e.(log R )
Categorical Population
odds ratio
(d1/h1) /
(d0/h0) s.e. =
1
+
1
+
1
+
1
1 1 0 0
logeOR
±1.96xs.e.(log eOR)
Calculation of p-values for comparing two groups
1 0
z =
s.e.(lo g ( RR ))
s.e.(log (OR))
Outcome
variable –
data type
Population parameter Population parameter
under null hypothesis
Test statistic
Categorical
π1-π0
Population risk ratio
Population odds ratio
π1-π0=0
Population risk ratio=1
Population odds ratio=1
p − p
s.e.( p
1
− p
0
)
z =
loge (RR)
e
z =
loge (OR)
e
Comparing the outcome measure of two exposure groups
(TBM trial: dexamethasone versus placebo)
Outcome
variable –
data type
Population
parameter
under null
hypothesis
Estimate of
population
parameter
from sample
95% confidence
interval for
population
parameter
Two-sided p-value
Categorical Population
risk
difference
= 0
p1-p0
= -0.095
-0.175, -0.015 0.020
Categorical
Population
risk ratio
= 1
p1/p0
= 0.77
0.62, 0.96 0.016
Categorical Population
odds ratio
= 1
(d1/h1) / (d0/h0)
= 0.66
0.46, 0.93 0.021
2×2 table – TBM trial example
Odds ratio for death = (d1/h1) / (d0/h0) = 0.465 / 0.704 = 0.66
Odds ratio for exposure to dexamethasone = (d1/d0) / (h1/h0) = 0.777 / 1.176 = 0.66
Odds ratio for not dying = (h1/d1) / (h0/d0) = 2.149 / 1.420 = 1.51 = (1/0.66)
Odds ratio for exposure to placebo = (d0/d1) / (h0/h1) = 1.287 / 0.850 = 1.51 = (1/0.66)
Death during 9 months post start
of treatment
Treatment group Yes No Total
Dexamethasone
(group 1)
87 (d1) 187 (h1) 274 (n1)
Placebo
(group 0)
112 (d0) 159 (h0) 271 (n0)
Total 199 346 545
Measure of association
Study Design Risk
difference
Risk
Ratio
Odds
Ratio
Randomised controlled trial
√ √ √
Cohort Study
√ √ √
Case-control Study
× × √
Lecture 10 – Controlling for confounding:
stratification and regression
• A description of confounding
• How to control for confounding
analysis by
– Stratification
– Regression modelling
in statistical
• A brief description of the role of multiple
linear or logistic regression in adjusting for
confounding
Outcome and exposure variables
(RECAP)
Outcomes are variables of interest (population
health relevance) whose patterns and
determinants we wish to learn about from data
•
• Exposures are the variables we think might
explain observed variation in the outcomes
• Statistical analysis can be used to quantify the
association between outcomes and exposures
What is confounding?
A confounding variable
1)
2)
3)
is associated with the outcome variable;
is associated with the exposure variable;
does not lie on the causal pathway.
Outcome variableExposure variable
Confounding variable
Failing to control for confounding may result in a
biased estimate of the magnitude of the association
between exposure and outcome
Example of confounding
Exposure variable Outcome variable
Alcohol intake Heart disease
Confounding variables
Cigarette smoking
Control of confounding
Design of Study
• Randomisation
(randomised controlled trial: e.g. TBM trial)
• Restriction
(only include those with one value of confounder)
• Matching
Control of confounding
Statistical analysis
• Stratification
• Regression modelling
Hypothetical example of a case-control study
Association between energy intake and heart disease
Odds
Odds
of heart disease in high energy intake group = 730/600 = 1.22
of heart disease in low energy intake group = 700/540 = 1.30
Odds ratio = 1.22 / 1.30 = 0.94
95% confidence interval: 0.80 up to 1.10
Heart disease
Energy intake Yes No Total
High
(group 1)
730 (d1) 600 (h1) 1330 (n1)
Low
(group 0)
700 (d0) 540 (h0) 1240 (n0)
Total 1430 1140 2570
Is this association confounded
by physical activity?
Exposure variable Outcome variable
Energy intake Heart disease
Confounding variables
Physical activity
Stratify by physical activity…..
Calculate the stratum specific odds ratios…
Energy
intake
High physical activity Low physical activity
Heart disease Heart disease
Yes No Yes No
High
(group 1)
500 510 230 90
Low
(group 0)
100 150 600 390
Stratify by physical activity…..
For high physical activity group:
OR (95% CI) = 1.47 (1.11, 1.95)
For low physical activity group:
OR (95% CI) = 1.66 (1.26, 2.19)
Energy
intake
High physical activity Low physical activity
Heart disease Heart disease
Yes No Yes No
High
(group 1)
500 510 230 90
Low
(group 0)
100 150 600 390
Is this association confounded
by physical
???
activity?
Exposure variable
Energy intake
Outcome variable
Heart disease
??????
Confounding variables
Physical activity
Confounding – condition 1
Association between physical activity and heart disease
** Look particularly in those who are not exposed to the factor of interest**
For low energy intake group:
OR (95% CI) = 0.43 (0.33, 0.58)
For high energy intake group:
OR (95% CI) = 0.38 (0.29, 0.50)
Physical
activity
High energy intake Low energy intake
Heart disease Heart disease
Yes No Yes No
High
(group 1)
500 510 100 150
Low
(group 0)
230 90 600 390
Confounding – condition 2
Association between energy intake and physical activity
• In a case-control study: examine the association in the controls
• In a cohort study: use the whole cohort
Confounding – condition 2
Association between energy intake and physical activity for those
without heart disease (n=1140)
Proportion in high energy intake group who report high physical activity =
510/600 = 0.85 (85%)
Proportion in low energy intake group who report high physical activity =
150/540 = 0.28 (28%)
Odds Ratio = (510/90) / (150/390) = 14.7; 95% CI: 11.0 up to 19.7
Physical activity
Energy intake High Low Total
High
(group 1)
510 90 600
Low
(group 0)
150 390 540
Is this association confounded
by physical
???
activity?
Exposure variable
Energy intake
Outcome variable
Heart disease
High energy intake:
OR = 0.38 (95% CI: 0.29, 0.50)
Low energy intake:
OR = 0.43 (95% CI: 0.33, 0.58)
High energy intake
associated
with high physical
activity
Confounding variables
Physical activity
So physical activity is a potential confounder
Control for confounding - Stratified analyses
1) Start with stratum specific estimates
differences, rate ratios
of odds ratios, risk ratios, risk
2) Calculate a weighted average of the
‘pooled’ estimate
stratum-specific estimates

Usual method is Mantel-Haenszel method
– Weights assigned according to amount of information in each
stratum
Calculate a pooled OR
(600×90)/1310) = 41.2
For low physical activity:
OR = 1.66
w= (d0×h1)/n =
For high physical activity:
OR = 1.47
w= (d0×h1)/n =
(100×510)/1260) = 40.5
Energy
intake
High physical activity
(n=1260)
Low physical activity
(n=1310)
Heart disease Heart disease
Yes No Yes No
High
(group 1)
500 (d1) 510 (h1) 230 (d1) 90 (h1)
Low
(group 0)
100 (d0) 150 (h0) 600 (d0) 390 (h0)
Calculate a pooled OR
(600×90)/1310) = 41.2
Mantel-Haenszel estimate of pooled odds ratio:
∑(wi × ORi )
OR =MH
∑wi
Stratum ‘i’
For low physical activity:
OR = 1.66
w= (d0×h1)/n =
For high physical activity:
OR = 1.47
w= (d0×h1)/n =
(100×510)/1260) = 40.5
Calculate a pooled OR
(600×90)/1310) = 41.2
Mantel-Haenszel estimate of pooled odds ratio:
(40.5×1.47) + (41.2×1.66)
OR =1.57=MH
(40.5+ 41.2)
95% CI: 1.29 up to 1.91
Recall that the crude OR was 0.94 (95% CI 0.80-1.10)
Is there a difference between crude
and adjusted measures of effect?
For low physical activity:
OR = 1.66
w= (d0×h1)/n =
For high physical activity:
OR = 1.47
w= (d0×h1)/n =
(100×510)/1260) = 40.5
Association between energy intake & heart
disease adjusting for physical activity
ORMH = 1.57
95% CI: 1.29, 1.91
Exposure variable
Energy intake
Outcome variable
Heart disease
High energy intake:
OR = 0.38 (95% CI: 0.29, 0.50)
Low energy intake:
OR = 0.43 (95% CI: 0.33, 0.58)
High energy intake
associated
with high physical
activity
Confounding variables
Physical activity
Multiple logistic regression
Outcome variable (y-variable) – binary
e.g. dead or alive; treatment failure or success;
disease or no disease..
Measure of association – Odds ratio
Multiple logistic regression model –
loge(odds of outcome) = β0 + β1X1 + β2X2 + β3X3 +…. + βkXk
β1,…βk – loge(odds ratios)
X1, …..Xk – k different exposure variables (do not need to
be binary but can be categorical with more than 2 categories
or numerical)
Useful when there are many confounding variables…
Logistic regression
Example – Association between energy intake and heart disease
Outcome variable (y-variable) – heart disease (coded as yes-1 & no-0)
Logistic regression model –
loge(odds of outcome) = β0 + β1X1
β1 – loge(odds ratios)
X1 – energy intake (high versus low)
Exposure Odds Ratio (expβi) 95% Confidence Interval
Energy intake
(high vs low)
0.94 0.80, 1.10
Multiple logistic regression
Example – Association between energy intake and heart disease
Outcome variable (y-variable) – heart disease (coded as yes-1 & no-0)
Multiple logistic regression model –
loge(odds of outcome) = β0 + β1X1 + β2X2
β1, β2 – loge(odds ratios)
X1 – energy intake (high versus low)
X2 – physical activity (high versus low)
Exposure Odds Ratio (expβi) 95% Confidence Interval
Energy intake
(high vs low)
1.57 1.29, 1.91
Physical activity
(high vs low)
0.41 0.33, 0.49
Multiple linear regression
Outcome variable (y-variable) – numerical
e.g. blood pressure, forced expiratory volume in 1 sec (FEV1)
Linear regression model –
y = β0 + β1X1 + β2X2 + β3X3 +…. + βkXk
y – numerical outcome variable,
β1,…βk – increase in y for every unit increase in x
X1, …..Xk – k different exposure variables (can be numerical
or categorical with 2+ categories)
Useful when there are many confounding variables…
Lecture 10 - Objectives
• Understand confounding
• Calculate the Mantel-Haenszel estimate of
pooled odds ratio
the
• Understand the difference between linear and
logistic regression
Thank You
www.HelpWithAssignment.com

More Related Content

What's hot

Survival analysis
Survival analysisSurvival analysis
Survival analysis
Har Jindal
 
Measurement of disease frequency
Measurement of disease frequencyMeasurement of disease frequency
Measurement of disease frequency
EhealthMoHS
 
Introduction To Survival Analysis
Introduction To Survival AnalysisIntroduction To Survival Analysis
Introduction To Survival Analysis
federicorotolo
 
Disabilty Adjusted Life Years(DALYs)
Disabilty Adjusted Life Years(DALYs)Disabilty Adjusted Life Years(DALYs)
Disabilty Adjusted Life Years(DALYs)
Abdur Razzaque Sarker, PhD
 
Epidemiology lecture 2 measuring disease frequency
Epidemiology lecture 2 measuring disease frequencyEpidemiology lecture 2 measuring disease frequency
Epidemiology lecture 2 measuring disease frequency
INAAMUL HAQ
 
Standerdization
StanderdizationStanderdization
Standerdization
Kunal Modak
 
Measures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortalityMeasures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortality
ADIL .
 
Malimu measures of disease frequency
Malimu measures of disease frequencyMalimu measures of disease frequency
Malimu measures of disease frequency
Miharbi Ignasm
 
Lecture of epidemiology
Lecture of epidemiologyLecture of epidemiology
Lecture of epidemiology
Amany El-seoud
 
Epidemiology
EpidemiologyEpidemiology
Epidemiology
anam arshad
 
DESCRIPTIVE EPIDEMIOLOGY
DESCRIPTIVE EPIDEMIOLOGYDESCRIPTIVE EPIDEMIOLOGY
DESCRIPTIVE EPIDEMIOLOGY
Shyam Chaturvedi
 
1. Introduction to epidemiological study designs
1. Introduction to epidemiological study designs1. Introduction to epidemiological study designs
1. Introduction to epidemiological study designs
Razif Shahril
 
Measures of disease frequency
Measures of disease frequency Measures of disease frequency
Measures of disease frequency
Dr Venkatesh Karthikeyan
 
Sample size by formula
Sample size by formulaSample size by formula
Sample size by formula
Mmedsc Hahm
 
Basic survival analysis
Basic survival analysisBasic survival analysis
Basic survival analysis
Mike LaValley
 
Estimating risk
Estimating riskEstimating risk
Estimating risk
Tarek Tawfik Amin
 
ODDS RATIO AND RELATIVE RISK EVALUATION
ODDS RATIO AND RELATIVE RISK EVALUATIONODDS RATIO AND RELATIVE RISK EVALUATION
ODDS RATIO AND RELATIVE RISK EVALUATION
Kanhu Charan
 
What does an odds ratio or relative risk mean?
What does an odds ratio or relative risk mean? What does an odds ratio or relative risk mean?
What does an odds ratio or relative risk mean?
Terry Shaneyfelt
 
Cross sectional study by Dr Abhishek Kumar
Cross sectional study by Dr Abhishek KumarCross sectional study by Dr Abhishek Kumar
Cross sectional study by Dr Abhishek Kumar
ak07mail
 
2. ph250b.14 measures of association 1
2.  ph250b.14  measures of association 12.  ph250b.14  measures of association 1
2. ph250b.14 measures of association 1
A M
 

What's hot (20)

Survival analysis
Survival analysisSurvival analysis
Survival analysis
 
Measurement of disease frequency
Measurement of disease frequencyMeasurement of disease frequency
Measurement of disease frequency
 
Introduction To Survival Analysis
Introduction To Survival AnalysisIntroduction To Survival Analysis
Introduction To Survival Analysis
 
Disabilty Adjusted Life Years(DALYs)
Disabilty Adjusted Life Years(DALYs)Disabilty Adjusted Life Years(DALYs)
Disabilty Adjusted Life Years(DALYs)
 
Epidemiology lecture 2 measuring disease frequency
Epidemiology lecture 2 measuring disease frequencyEpidemiology lecture 2 measuring disease frequency
Epidemiology lecture 2 measuring disease frequency
 
Standerdization
StanderdizationStanderdization
Standerdization
 
Measures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortalityMeasures of Disease, Morbidity& mortality
Measures of Disease, Morbidity& mortality
 
Malimu measures of disease frequency
Malimu measures of disease frequencyMalimu measures of disease frequency
Malimu measures of disease frequency
 
Lecture of epidemiology
Lecture of epidemiologyLecture of epidemiology
Lecture of epidemiology
 
Epidemiology
EpidemiologyEpidemiology
Epidemiology
 
DESCRIPTIVE EPIDEMIOLOGY
DESCRIPTIVE EPIDEMIOLOGYDESCRIPTIVE EPIDEMIOLOGY
DESCRIPTIVE EPIDEMIOLOGY
 
1. Introduction to epidemiological study designs
1. Introduction to epidemiological study designs1. Introduction to epidemiological study designs
1. Introduction to epidemiological study designs
 
Measures of disease frequency
Measures of disease frequency Measures of disease frequency
Measures of disease frequency
 
Sample size by formula
Sample size by formulaSample size by formula
Sample size by formula
 
Basic survival analysis
Basic survival analysisBasic survival analysis
Basic survival analysis
 
Estimating risk
Estimating riskEstimating risk
Estimating risk
 
ODDS RATIO AND RELATIVE RISK EVALUATION
ODDS RATIO AND RELATIVE RISK EVALUATIONODDS RATIO AND RELATIVE RISK EVALUATION
ODDS RATIO AND RELATIVE RISK EVALUATION
 
What does an odds ratio or relative risk mean?
What does an odds ratio or relative risk mean? What does an odds ratio or relative risk mean?
What does an odds ratio or relative risk mean?
 
Cross sectional study by Dr Abhishek Kumar
Cross sectional study by Dr Abhishek KumarCross sectional study by Dr Abhishek Kumar
Cross sectional study by Dr Abhishek Kumar
 
2. ph250b.14 measures of association 1
2.  ph250b.14  measures of association 12.  ph250b.14  measures of association 1
2. ph250b.14 measures of association 1
 

Viewers also liked

Succession “Losers”: What Happens to Executives Passed Over for the CEO Job?
Succession “Losers”: What Happens to Executives Passed Over for the CEO Job? Succession “Losers”: What Happens to Executives Passed Over for the CEO Job?
Succession “Losers”: What Happens to Executives Passed Over for the CEO Job?
Stanford GSB Corporate Governance Research Initiative
 
The impact of innovation on travel and tourism industries (World Travel Marke...
The impact of innovation on travel and tourism industries (World Travel Marke...The impact of innovation on travel and tourism industries (World Travel Marke...
The impact of innovation on travel and tourism industries (World Travel Marke...
Brian Solis
 
Open Source Creativity
Open Source CreativityOpen Source Creativity
Open Source Creativity
Sara Cannon
 
Reuters: Pictures of the Year 2016 (Part 2)
Reuters: Pictures of the Year 2016 (Part 2)Reuters: Pictures of the Year 2016 (Part 2)
Reuters: Pictures of the Year 2016 (Part 2)
maditabalnco
 
The Six Highest Performing B2B Blog Post Formats
The Six Highest Performing B2B Blog Post FormatsThe Six Highest Performing B2B Blog Post Formats
The Six Highest Performing B2B Blog Post Formats
Barry Feldman
 
The Outcome Economy
The Outcome EconomyThe Outcome Economy
The Outcome Economy
Helge Tennø
 

Viewers also liked (6)

Succession “Losers”: What Happens to Executives Passed Over for the CEO Job?
Succession “Losers”: What Happens to Executives Passed Over for the CEO Job? Succession “Losers”: What Happens to Executives Passed Over for the CEO Job?
Succession “Losers”: What Happens to Executives Passed Over for the CEO Job?
 
The impact of innovation on travel and tourism industries (World Travel Marke...
The impact of innovation on travel and tourism industries (World Travel Marke...The impact of innovation on travel and tourism industries (World Travel Marke...
The impact of innovation on travel and tourism industries (World Travel Marke...
 
Open Source Creativity
Open Source CreativityOpen Source Creativity
Open Source Creativity
 
Reuters: Pictures of the Year 2016 (Part 2)
Reuters: Pictures of the Year 2016 (Part 2)Reuters: Pictures of the Year 2016 (Part 2)
Reuters: Pictures of the Year 2016 (Part 2)
 
The Six Highest Performing B2B Blog Post Formats
The Six Highest Performing B2B Blog Post FormatsThe Six Highest Performing B2B Blog Post Formats
The Six Highest Performing B2B Blog Post Formats
 
The Outcome Economy
The Outcome EconomyThe Outcome Economy
The Outcome Economy
 

Similar to Measures of association - Biostatistics

Proportions and Confidence Intervals in Biostatistics
Proportions and Confidence Intervals in BiostatisticsProportions and Confidence Intervals in Biostatistics
Proportions and Confidence Intervals in Biostatistics
HelpWithAssignment.com
 
Statistical Journal club
Statistical Journal club Statistical Journal club
Statistical Journal club
FATEMEH Soleimany
 
Sesi 5 b ukuran dampak.2009l
Sesi 5 b ukuran dampak.2009lSesi 5 b ukuran dampak.2009l
Sesi 5 b ukuran dampak.2009l
NANTRIW
 
2014 lab slides_mo_a
2014 lab slides_mo_a2014 lab slides_mo_a
2014 lab slides_mo_a
A M
 
Common measures of association in medical research (UPDATED) 2013
Common measures of association in medical research (UPDATED) 2013Common measures of association in medical research (UPDATED) 2013
Common measures of association in medical research (UPDATED) 2013
Pat Barlow
 
Categorical data analysis full lecture note PPT.pptx
Categorical data analysis full lecture note  PPT.pptxCategorical data analysis full lecture note  PPT.pptx
Categorical data analysis full lecture note PPT.pptx
MinilikDerseh1
 
Risk factors explained_v01
Risk factors explained_v01Risk factors explained_v01
Risk factors explained_v01
Nick Portokallidis
 
4.3.2. controlling confounding stratification
4.3.2. controlling confounding stratification4.3.2. controlling confounding stratification
4.3.2. controlling confounding stratification
A M
 
MD Paediatricts (Part 2) - Epidemiology and Statistics
MD Paediatricts (Part 2) - Epidemiology and StatisticsMD Paediatricts (Part 2) - Epidemiology and Statistics
MD Paediatricts (Part 2) - Epidemiology and Statistics
Bernard Deepal W. Jayamanne
 
Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statistics
Hesham Al-Inany
 
ODDS RATIO & MENTEL-HAESZEL ODDS RATIO
ODDS RATIO & MENTEL-HAESZEL ODDS RATIOODDS RATIO & MENTEL-HAESZEL ODDS RATIO
ODDS RATIO & MENTEL-HAESZEL ODDS RATIO
Dr.Benny PV
 
Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statisticsHesham Gaber
 
chapter15c.ppt
chapter15c.pptchapter15c.ppt
chapter15c.ppt
MohamedSahal16
 
chapter15c.ppt
chapter15c.pptchapter15c.ppt
chapter15c.ppt
dawitg2
 
34301
3430134301
34301
Alok Roy
 
Chapter 9Multivariable MethodsObjectives• .docx
Chapter 9Multivariable MethodsObjectives• .docxChapter 9Multivariable MethodsObjectives• .docx
Chapter 9Multivariable MethodsObjectives• .docx
spoonerneddy
 
Case control study - Part 2
Case control study - Part 2Case control study - Part 2
Case control study - Part 2Rizwan S A
 
Parametric Test.pptx
Parametric Test.pptxParametric Test.pptx
Parametric Test.pptx
Satyendra Singh Yadav
 
Matching Weights to Simultaneously Compare Three Treatment Groups: a Simulati...
Matching Weights to Simultaneously Compare Three Treatment Groups: a Simulati...Matching Weights to Simultaneously Compare Three Treatment Groups: a Simulati...
Matching Weights to Simultaneously Compare Three Treatment Groups: a Simulati...
Kazuki Yoshida
 
Nuts & Bolts of Systematic Reviews, Meta-analyses & Network Meta-analyses
Nuts & Bolts of Systematic Reviews, Meta-analyses & Network Meta-analysesNuts & Bolts of Systematic Reviews, Meta-analyses & Network Meta-analyses
Nuts & Bolts of Systematic Reviews, Meta-analyses & Network Meta-analyses
OARSI
 

Similar to Measures of association - Biostatistics (20)

Proportions and Confidence Intervals in Biostatistics
Proportions and Confidence Intervals in BiostatisticsProportions and Confidence Intervals in Biostatistics
Proportions and Confidence Intervals in Biostatistics
 
Statistical Journal club
Statistical Journal club Statistical Journal club
Statistical Journal club
 
Sesi 5 b ukuran dampak.2009l
Sesi 5 b ukuran dampak.2009lSesi 5 b ukuran dampak.2009l
Sesi 5 b ukuran dampak.2009l
 
2014 lab slides_mo_a
2014 lab slides_mo_a2014 lab slides_mo_a
2014 lab slides_mo_a
 
Common measures of association in medical research (UPDATED) 2013
Common measures of association in medical research (UPDATED) 2013Common measures of association in medical research (UPDATED) 2013
Common measures of association in medical research (UPDATED) 2013
 
Categorical data analysis full lecture note PPT.pptx
Categorical data analysis full lecture note  PPT.pptxCategorical data analysis full lecture note  PPT.pptx
Categorical data analysis full lecture note PPT.pptx
 
Risk factors explained_v01
Risk factors explained_v01Risk factors explained_v01
Risk factors explained_v01
 
4.3.2. controlling confounding stratification
4.3.2. controlling confounding stratification4.3.2. controlling confounding stratification
4.3.2. controlling confounding stratification
 
MD Paediatricts (Part 2) - Epidemiology and Statistics
MD Paediatricts (Part 2) - Epidemiology and StatisticsMD Paediatricts (Part 2) - Epidemiology and Statistics
MD Paediatricts (Part 2) - Epidemiology and Statistics
 
Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statistics
 
ODDS RATIO & MENTEL-HAESZEL ODDS RATIO
ODDS RATIO & MENTEL-HAESZEL ODDS RATIOODDS RATIO & MENTEL-HAESZEL ODDS RATIO
ODDS RATIO & MENTEL-HAESZEL ODDS RATIO
 
Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statistics
 
chapter15c.ppt
chapter15c.pptchapter15c.ppt
chapter15c.ppt
 
chapter15c.ppt
chapter15c.pptchapter15c.ppt
chapter15c.ppt
 
34301
3430134301
34301
 
Chapter 9Multivariable MethodsObjectives• .docx
Chapter 9Multivariable MethodsObjectives• .docxChapter 9Multivariable MethodsObjectives• .docx
Chapter 9Multivariable MethodsObjectives• .docx
 
Case control study - Part 2
Case control study - Part 2Case control study - Part 2
Case control study - Part 2
 
Parametric Test.pptx
Parametric Test.pptxParametric Test.pptx
Parametric Test.pptx
 
Matching Weights to Simultaneously Compare Three Treatment Groups: a Simulati...
Matching Weights to Simultaneously Compare Three Treatment Groups: a Simulati...Matching Weights to Simultaneously Compare Three Treatment Groups: a Simulati...
Matching Weights to Simultaneously Compare Three Treatment Groups: a Simulati...
 
Nuts & Bolts of Systematic Reviews, Meta-analyses & Network Meta-analyses
Nuts & Bolts of Systematic Reviews, Meta-analyses & Network Meta-analysesNuts & Bolts of Systematic Reviews, Meta-analyses & Network Meta-analyses
Nuts & Bolts of Systematic Reviews, Meta-analyses & Network Meta-analyses
 

Recently uploaded

Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 

Recently uploaded (20)

Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 

Measures of association - Biostatistics

  • 2. Lecture 9 Review – Measures of association Measures of association – – – Risk difference Risk ratio Odds ratio Calculation & interpretation interval for each measure of confidence of association
  • 3. 2×2 table - Measures of association Outcome - binary Measure of Effect Formula Risk difference p1-p0 Risk ratio p1 / p0 Odds ratio (d1/h1) / (d0/h0)
  • 4. Differences in measures of association • When there is no association between exposure and outcome, – – – risk difference = 0 risk ratio (RR) = 1 odds ratio (OR) = 1 • • Risk difference can be negative or positive RR & OR are always positive • For rare outcomes, OR ~ RR • OR is always further from 1 than corresponding RR – If RR > 1 then OR > RR – If RR < 1 the OR < RR
  • 5. Interpretation of measures of association • RR & OR < 1, associated with a reduced risk / odds (may protective) be – RR = 0.8 (reduced risk of 20%) • RR – & OR > 1, associated with an increased risk / odds RR = 1.2 (increased risk of 20%) • RR & OR – further the risk is from 1, stronger the association between exposure and outcome (e.g. RR=2 versus RR=3).
  • 6. Comparing the outcome measure of two exposure groups (groups 1 & 0) s.e.(log RR) = − + −e eR (log e OR ) d h d h Outcome variable – data type Population parameter Estimate of population parameter from sample Standard error of loge(parameter) 95% Confidence interval of loge(population parameter) Categorical Population risk ratio p1/p0 1 1 1 1 d1 n1 d0 n0 logeRR ±1.96× s.e.(log R ) Categorical Population odds ratio (d1/h1) / (d0/h0) s.e. = 1 + 1 + 1 + 1 1 1 0 0 logeOR ±1.96xs.e.(log eOR)
  • 7. Calculation of p-values for comparing two groups 1 0 z = s.e.(lo g ( RR )) s.e.(log (OR)) Outcome variable – data type Population parameter Population parameter under null hypothesis Test statistic Categorical π1-π0 Population risk ratio Population odds ratio π1-π0=0 Population risk ratio=1 Population odds ratio=1 p − p s.e.( p 1 − p 0 ) z = loge (RR) e z = loge (OR) e
  • 8. Comparing the outcome measure of two exposure groups (TBM trial: dexamethasone versus placebo) Outcome variable – data type Population parameter under null hypothesis Estimate of population parameter from sample 95% confidence interval for population parameter Two-sided p-value Categorical Population risk difference = 0 p1-p0 = -0.095 -0.175, -0.015 0.020 Categorical Population risk ratio = 1 p1/p0 = 0.77 0.62, 0.96 0.016 Categorical Population odds ratio = 1 (d1/h1) / (d0/h0) = 0.66 0.46, 0.93 0.021
  • 9. 2×2 table – TBM trial example Odds ratio for death = (d1/h1) / (d0/h0) = 0.465 / 0.704 = 0.66 Odds ratio for exposure to dexamethasone = (d1/d0) / (h1/h0) = 0.777 / 1.176 = 0.66 Odds ratio for not dying = (h1/d1) / (h0/d0) = 2.149 / 1.420 = 1.51 = (1/0.66) Odds ratio for exposure to placebo = (d0/d1) / (h0/h1) = 1.287 / 0.850 = 1.51 = (1/0.66) Death during 9 months post start of treatment Treatment group Yes No Total Dexamethasone (group 1) 87 (d1) 187 (h1) 274 (n1) Placebo (group 0) 112 (d0) 159 (h0) 271 (n0) Total 199 346 545
  • 10. Measure of association Study Design Risk difference Risk Ratio Odds Ratio Randomised controlled trial √ √ √ Cohort Study √ √ √ Case-control Study × × √
  • 11. Lecture 10 – Controlling for confounding: stratification and regression • A description of confounding • How to control for confounding analysis by – Stratification – Regression modelling in statistical • A brief description of the role of multiple linear or logistic regression in adjusting for confounding
  • 12. Outcome and exposure variables (RECAP) Outcomes are variables of interest (population health relevance) whose patterns and determinants we wish to learn about from data • • Exposures are the variables we think might explain observed variation in the outcomes • Statistical analysis can be used to quantify the association between outcomes and exposures
  • 13. What is confounding? A confounding variable 1) 2) 3) is associated with the outcome variable; is associated with the exposure variable; does not lie on the causal pathway. Outcome variableExposure variable Confounding variable Failing to control for confounding may result in a biased estimate of the magnitude of the association between exposure and outcome
  • 14. Example of confounding Exposure variable Outcome variable Alcohol intake Heart disease Confounding variables Cigarette smoking
  • 15. Control of confounding Design of Study • Randomisation (randomised controlled trial: e.g. TBM trial) • Restriction (only include those with one value of confounder) • Matching
  • 16. Control of confounding Statistical analysis • Stratification • Regression modelling
  • 17. Hypothetical example of a case-control study Association between energy intake and heart disease Odds Odds of heart disease in high energy intake group = 730/600 = 1.22 of heart disease in low energy intake group = 700/540 = 1.30 Odds ratio = 1.22 / 1.30 = 0.94 95% confidence interval: 0.80 up to 1.10 Heart disease Energy intake Yes No Total High (group 1) 730 (d1) 600 (h1) 1330 (n1) Low (group 0) 700 (d0) 540 (h0) 1240 (n0) Total 1430 1140 2570
  • 18. Is this association confounded by physical activity? Exposure variable Outcome variable Energy intake Heart disease Confounding variables Physical activity
  • 19. Stratify by physical activity….. Calculate the stratum specific odds ratios… Energy intake High physical activity Low physical activity Heart disease Heart disease Yes No Yes No High (group 1) 500 510 230 90 Low (group 0) 100 150 600 390
  • 20. Stratify by physical activity….. For high physical activity group: OR (95% CI) = 1.47 (1.11, 1.95) For low physical activity group: OR (95% CI) = 1.66 (1.26, 2.19) Energy intake High physical activity Low physical activity Heart disease Heart disease Yes No Yes No High (group 1) 500 510 230 90 Low (group 0) 100 150 600 390
  • 21. Is this association confounded by physical ??? activity? Exposure variable Energy intake Outcome variable Heart disease ?????? Confounding variables Physical activity
  • 22. Confounding – condition 1 Association between physical activity and heart disease ** Look particularly in those who are not exposed to the factor of interest** For low energy intake group: OR (95% CI) = 0.43 (0.33, 0.58) For high energy intake group: OR (95% CI) = 0.38 (0.29, 0.50) Physical activity High energy intake Low energy intake Heart disease Heart disease Yes No Yes No High (group 1) 500 510 100 150 Low (group 0) 230 90 600 390
  • 23. Confounding – condition 2 Association between energy intake and physical activity • In a case-control study: examine the association in the controls • In a cohort study: use the whole cohort
  • 24. Confounding – condition 2 Association between energy intake and physical activity for those without heart disease (n=1140) Proportion in high energy intake group who report high physical activity = 510/600 = 0.85 (85%) Proportion in low energy intake group who report high physical activity = 150/540 = 0.28 (28%) Odds Ratio = (510/90) / (150/390) = 14.7; 95% CI: 11.0 up to 19.7 Physical activity Energy intake High Low Total High (group 1) 510 90 600 Low (group 0) 150 390 540
  • 25. Is this association confounded by physical ??? activity? Exposure variable Energy intake Outcome variable Heart disease High energy intake: OR = 0.38 (95% CI: 0.29, 0.50) Low energy intake: OR = 0.43 (95% CI: 0.33, 0.58) High energy intake associated with high physical activity Confounding variables Physical activity
  • 26. So physical activity is a potential confounder Control for confounding - Stratified analyses 1) Start with stratum specific estimates differences, rate ratios of odds ratios, risk ratios, risk 2) Calculate a weighted average of the ‘pooled’ estimate stratum-specific estimates  Usual method is Mantel-Haenszel method – Weights assigned according to amount of information in each stratum
  • 27. Calculate a pooled OR (600×90)/1310) = 41.2 For low physical activity: OR = 1.66 w= (d0×h1)/n = For high physical activity: OR = 1.47 w= (d0×h1)/n = (100×510)/1260) = 40.5 Energy intake High physical activity (n=1260) Low physical activity (n=1310) Heart disease Heart disease Yes No Yes No High (group 1) 500 (d1) 510 (h1) 230 (d1) 90 (h1) Low (group 0) 100 (d0) 150 (h0) 600 (d0) 390 (h0)
  • 28. Calculate a pooled OR (600×90)/1310) = 41.2 Mantel-Haenszel estimate of pooled odds ratio: ∑(wi × ORi ) OR =MH ∑wi Stratum ‘i’ For low physical activity: OR = 1.66 w= (d0×h1)/n = For high physical activity: OR = 1.47 w= (d0×h1)/n = (100×510)/1260) = 40.5
  • 29. Calculate a pooled OR (600×90)/1310) = 41.2 Mantel-Haenszel estimate of pooled odds ratio: (40.5×1.47) + (41.2×1.66) OR =1.57=MH (40.5+ 41.2) 95% CI: 1.29 up to 1.91 Recall that the crude OR was 0.94 (95% CI 0.80-1.10) Is there a difference between crude and adjusted measures of effect? For low physical activity: OR = 1.66 w= (d0×h1)/n = For high physical activity: OR = 1.47 w= (d0×h1)/n = (100×510)/1260) = 40.5
  • 30. Association between energy intake & heart disease adjusting for physical activity ORMH = 1.57 95% CI: 1.29, 1.91 Exposure variable Energy intake Outcome variable Heart disease High energy intake: OR = 0.38 (95% CI: 0.29, 0.50) Low energy intake: OR = 0.43 (95% CI: 0.33, 0.58) High energy intake associated with high physical activity Confounding variables Physical activity
  • 31. Multiple logistic regression Outcome variable (y-variable) – binary e.g. dead or alive; treatment failure or success; disease or no disease.. Measure of association – Odds ratio Multiple logistic regression model – loge(odds of outcome) = β0 + β1X1 + β2X2 + β3X3 +…. + βkXk β1,…βk – loge(odds ratios) X1, …..Xk – k different exposure variables (do not need to be binary but can be categorical with more than 2 categories or numerical) Useful when there are many confounding variables…
  • 32. Logistic regression Example – Association between energy intake and heart disease Outcome variable (y-variable) – heart disease (coded as yes-1 & no-0) Logistic regression model – loge(odds of outcome) = β0 + β1X1 β1 – loge(odds ratios) X1 – energy intake (high versus low) Exposure Odds Ratio (expβi) 95% Confidence Interval Energy intake (high vs low) 0.94 0.80, 1.10
  • 33. Multiple logistic regression Example – Association between energy intake and heart disease Outcome variable (y-variable) – heart disease (coded as yes-1 & no-0) Multiple logistic regression model – loge(odds of outcome) = β0 + β1X1 + β2X2 β1, β2 – loge(odds ratios) X1 – energy intake (high versus low) X2 – physical activity (high versus low) Exposure Odds Ratio (expβi) 95% Confidence Interval Energy intake (high vs low) 1.57 1.29, 1.91 Physical activity (high vs low) 0.41 0.33, 0.49
  • 34. Multiple linear regression Outcome variable (y-variable) – numerical e.g. blood pressure, forced expiratory volume in 1 sec (FEV1) Linear regression model – y = β0 + β1X1 + β2X2 + β3X3 +…. + βkXk y – numerical outcome variable, β1,…βk – increase in y for every unit increase in x X1, …..Xk – k different exposure variables (can be numerical or categorical with 2+ categories) Useful when there are many confounding variables…
  • 35. Lecture 10 - Objectives • Understand confounding • Calculate the Mantel-Haenszel estimate of pooled odds ratio the • Understand the difference between linear and logistic regression